1. EP874 Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort. (1st November 2019) Authors: Idahl, A; Le Cornet, C; González Maldonado, S; Waterboer, T; Bender, N; Tjønneland, A; Hansen, L; Boutron-Ruault, M-C; Fournier, A; Kvaskoff, M; Boeing, H; Trichopoulou, A; Valanou, E; Peppa, E; Palli, D; Agnoli, C; Mattiello, A; Tumino, R; Sacerdote, C; Onland-Moret, C Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P131Chlamydia trachomatis and anti-MUC1 antibodies and subsequent risk of high grade serous ovarian cancer: a population-based case-control study in northern sweden. (1st November 2019) Authors: Jonsson, S; Lundin, E; Elgh, F; Ottander, U; Idahl, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗